Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Machine Learning Tool Gives Early Warning of Cardiac Issues or Blood Clots in COVID Patients

By HospiMedica International staff writers
Posted on 15 Jan 2021
A team of biomedical engineers and heart specialists have developed an algorithm that warns doctors several hours before hospitalized COVID-19 patients experience cardiac arrest or blood clots.

The COVID-HEART predictor developed using data from patients treated for COVID-19 by scientists at the Johns Hopkins University (JHU; Baltimore, MD, USA) can forecast cardiac arrest in COVID-19 patients with a median early warning time of 18 hours and predict blood clots three days in advance. More...
The machine-learning algorithm was built with more than 100 clinical data points, demographic information and laboratory results obtained from the JH-CROWN registry that Johns Hopkins established to collect COVID data from every patient in the hospital system. The scientists also added other variables reported by doctors on Twitter and from other pre-print papers.

The team did not anticipate that electrocardiogram data would play a critical role in the prediction of blood clotting. But once it was added, ECG data became one of the most accurate indicators for the condition. The next step for the researchers is to develop the best method for setting up the technology in hospitals to aid with the care of COVID-19 patients.

“It’s an early warning system to predict in real time these two outcomes in hospitalized COVID patients,” said senior author Natalia Trayanova, the Murray B. Sachs professor of Biomedical Engineering and a professor of medicine. “The continuously updating predictor can help hospitals allocate the appropriate resources and proper interventions to attain the best outcomes for patients.”

“The COVID-HEART predictor tool could help in the rapid triage of COVID-19 patients in the clinical setting especially when resources are limited,” said Allison Hays, associate professor of medicine in the Johns Hopkins University School of Medicine and the project’s main clinical collaborator. “This may have implications for the treatment and closer monitoring of Covid-19 patients to help prevent these poor outcomes.”

Related Links:
Johns Hopkins University


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Medical Examination & Procedure Light
Vega 80
New
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.